This new analysis of 5-year data on a novel gene therapy from PTC Therapeutics shows both cognitive and motor function improvement in children with aromatic L-amino acid decarboxylase (AADC) ...
Five-year-old Boston Yannotti’s ear-to-ear smile masks what has been an extremely difficult childhood. The young boy, with reddish-brown hair and bright blue eyes like his mother, has been confined ...
The Food and Drug Administration (FDA) has granted accelerated approval to Kebilidi™ (eladocagene exuparvovec-tneq) for the treatment of adult and pediatric patients with aromatic L-amino acid ...
The study portrays the intense need for daily care experienced by children with aromatic L-Amino acid decarboxylase deficiency (AADC-d) and their families. Parents or caregivers of children with the ...
Logan Lacy has spent his 4.5 years trapped in a body controlled by a newborn's nervous system. He has never run or climbed like kids his age, let alone sit up on his own or speak. But his parents, ...
SOUTH PLAINFIELD, N.J., May 17, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced data from the first study on the impact of caring for a child with the ultra-rare genetic ...
“This is nothing short of a miracle," mom Shante Stagg told TODAY of a gene therapy that has helped her son who has a rare health condition. After a complicated birth, Jamell Stagg Jr.’s parents ...
Three-year-old Gunreet Kaur, with her mother Sandeep Kaur (right), who is affected by a life-threatening condition and is the youngest person in the UK to receive a groundbreaking gene therapy (Family ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results